December 13, 2010
The Case Comprehensive Cancer Center is pleased to announce the recipients of pilot funding to support basic, clinical or translational human tissue based research. The purpose of these awards is to foster collaborations and to promote and increase institution-wide capacity and competitiveness in research.
James Jacobberger, PhD: Cell Signaling as an Acute Myeloid Leukemia Biomarker
Ruth Keri, PhD: Follistatin as an Inhibitor of Metastatic Progression in Breast Cancer
Andrew Sloan, MD: Targeted Proteomics to Predict Differential Glioblastoma Survival
Jill Barnholtz-Sloan, PhD: Development of Human Brain Tumor Tissue Microarrays
Ge Jin, PhD: Human β-defensins as Novel Biomarkers for Precancerous Lesions of Colorectal Cancer
Cheryl Thompson, PhD: A Biorepository for Research in Lung Cancer Risk, Detection and Prognosis
William Schiemann, PhD Oncogenic TGF-β Effectors are Novel Biomarkers for Recurrent Cancer
Related Sites:
Seidman Cancer Center | Taussig Cancer Institute | University Hospitals | Cleveland Clinic | National Cancer Institute |
Case Western Reserve University Home | Clinical & Translational Science Collaborative
About Us | Contact Us | Email Webmaster
Case Comprehensive Cancer Center | 11100 Euclid Avenue | Cleveland, Ohio 44106-5065 | Phone: 216.844.8797
© 2011 Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106 216.368.2000 (legal notice)